TY  - INPR
AV  - public
KW  - ATRX
KW  -  Astrocytoma
KW  -  BRAF
KW  -  BRAF inhibitor
KW  -  EGFR
KW  -  Ependymoma
KW  -  Glioblastoma
KW  -  Histone
KW  -  IDH
KW  -  MGMT
KW  -  Mutation
KW  -  Oligodendroglioma
KW  -  TERT
KW  -  Temozolomide
KW  -  Tumour heterogeneity
N2  - The emerging understanding of molecular changes in a wide range of brain tumours has led to a significant shift in how these tumours are diagnosed, managed and treated. This article will provide a hands-on overview of the relevant biomarkers and their association with newly defined biological tumour entities.
A1  - Brandner, S
A1  - Jaunmuktane, Z
SN  - 1432-1459
JF  - J Neurol
N1  - © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
TI  - Neurological update: gliomas and other primary brain tumours in adults.
Y1  - 2017/11/02/
UR  - http://dx.doi.org/10.1007/s00415-017-8652-3
ID  - discovery10035305
ER  -